Matrix Gla Protein (MGP) (Middle Region) Peptid
MGP
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Produktnummer ABIN980069
Kurzübersicht für Matrix Gla Protein (MGP) (Middle Region) Peptid (ABIN980069)
Target
MGP
(Matrix Gla Protein (MGP))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-MGP antibody (Catalog #: ARP51308_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
Matrix Gla Protein (MGP) (AA 20-96) peptide (His tag)
MGP Reaktivität: Human Wirt: Escherichia coli (E. coli) SDS
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MGP (Matrix Gla Protein (MGP))
-
Hintergrund
-
MGP is associates with the organic matrix of bone and cartilage. MGP is thought to act as an inhibitor of bone formation.
Alias Symbols: GIG36, MGLAP, NTI
Protein Interaction Partner: BMP2,BMP2
Protein Size: 103 -
Molekulargewicht
- 12 kDa
-
Gen-ID
- 4256
-
NCBI Accession
- NM_000900, NP_000891
-
UniProt
- P08493
Target
-
Sie sind hier:
